» Articles » PMID: 35900708

Maximizing the Impact of Voluntary Medical Male Circumcision for HIV Prevention in Zambia by Targeting High-Risk Men: A Pre/Post Program Evaluation

Overview
Journal AIDS Behav
Date 2022 Jul 28
PMID 35900708
Authors
Affiliations
Soon will be listed here.
Abstract

A well-documented barrier to voluntary medical male circumcision (VMMC) is financial loss due to the missed opportunity to work while undergoing and recovering from VMMC. We implemented a 2-phased outcome evaluation to explore how enhanced demand creation and financial compensation equivalent to 3 days of missed work influence uptake of VMMC among men at high risk of HIV exposure in Zambia. In Phase 1, we implemented human-centered design-informed interpersonal communication. In Phase 2, financial compensation of ZMW 200 (~ US$17) was added. The proportion of men undergoing circumcision was significantly higher in Phase 2 compared to Phase 1 (38% vs 3%). The cost of demand creation and compensation per client circumcised was $151.54 in Phase 1 and $34.93 in Phase 2. Financial compensation is a cost-effective strategy for increasing VMMC uptake among high-risk men in Zambia, and VMMC programs may consider similar interventions suited to their context.

Citing Articles

Effectiveness of an intervention to increase uptake of voluntary medical male circumcision among men with sexually transmitted infections in Malawi: a preinterventional and postinterventional study.

Matoga M, Kudowa E, Ndalama B, Bonongwe N, Mathiya E, Jere E BMJ Open. 2023; 13(10):e072855.

PMID: 37788927 PMC: 10552000. DOI: 10.1136/bmjopen-2023-072855.


Factors Beyond Compensation Associated with Uptake of Voluntary Medical Male Circumcision in Zambia.

Ong K, Laube C, Mohan D, Iverson L, Kaonga A, Chituwo O AIDS Behav. 2022; 27(6):1836-1848.

PMID: 36357807 PMC: 10979468. DOI: 10.1007/s10461-022-03915-y.

References
1.
Carrasco M, Grund J, Davis S, Ridzon R, Mattingly M, Wilkinson J . Systematic review of the effect of economic compensation and incentives on uptake of voluntary medical male circumcision among men in sub-Saharan Africa. AIDS Care. 2018; 30(9):1071-1082. PMC: 6800131. DOI: 10.1080/09540121.2018.1453921. View

2.
Price J, Phiri L, Mulenga D, Hewett P, Topp S, Shiliya N . Behavior change pathways to voluntary medical male circumcision: narrative interviews with circumcision clients in Zambia. PLoS One. 2014; 9(11):e111602. PMC: 4222873. DOI: 10.1371/journal.pone.0111602. View

3.
H Gray R, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F . Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007; 369(9562):657-66. DOI: 10.1016/S0140-6736(07)60313-4. View

4.
Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A . Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005; 2(11):e298. PMC: 1262556. DOI: 10.1371/journal.pmed.0020298. View

5.
Ensor S, Davies B, Rai T, Ward H . The effectiveness of demand creation interventions for voluntary male medical circumcision for HIV prevention in sub-Saharan Africa: a mixed methods systematic review. J Int AIDS Soc. 2019; 22 Suppl 4:e25299. PMC: 6643070. DOI: 10.1002/jia2.25299. View